Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.

@article{Eckstein2012DirectCO,
  title={Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.},
  author={Jens Eckstein and Mihael Potocki and Karsten Murray and Tobias Breidthardt and Ronny Ziller and Tamina Mosimann and Theresia Klima and Rebeca Hoeller and Berit Moehring and Seoung Mann Sou and Mar{\'i}a Rubini Gim{\'e}nez and Nils G. Morgenthaler and Christian M{\"u}ller},
  journal={Heart},
  year={2012},
  volume={98 20},
  pages={1518-22}
}
OBJECTIVES Due to different release mechanisms, mid-regional pro-atrial natriuretic peptide (MR proANP) may be superior to N-terminal pro-B-type natriuretic peptide (NT proBNP) in the diagnosis of acute heart failure (AHF) in patients with atrial fibrillation (AF). We compared MR proANP and NT proBNP for their diagnostic value in patients with AF and sinus rhythm (SR). DESIGN Prospective cohort study. SETTING University hospital, emergency department. PATIENTS 632 consecutive patients… CONTINUE READING